Seeking Alpha

Complete Genomics' (GNOM +5.3%) restructuring and postponement of capacity expansion are...

Complete Genomics' (GNOM +5.3%) restructuring and postponement of capacity expansion are incremental positives for Illumina (ILMN +1.1%), observes Leerink Swann. The firm says v pricing in the whole human genome sequencing market could stabilize as a result of GNOM' actions.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)